GLA supplementation regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DMBA induced mammary gland carcinoma

Area of Science:

• Biochemistry
• Oncology
• Metabolomics

Background:

• Mammary gland carcinoma poses a significant health challenge.
• 7,12-dimethylbenz(a)anthracene (DMBA) is a known carcinogen used to induce mammary tumors in research models.
• Understanding the molecular mechanisms of cancer development and potential therapeutic interventions is crucial.

Purpose of the Study:

• To investigate the therapeutic potential of gamma linolenic acid (GLA) in a chemically induced mammary gland carcinoma model.
• To evaluate GLA's effects on apoptosis, the tumor microenvironment, and inflammatory pathways.
• To analyze metabolic alterations associated with GLA treatment using nuclear magnetic resonance (NMR) spectroscopy.

Main Methods:

• Induction of mammary gland carcinoma using 7,12-dimethylbenz(a)anthracene (DMBA).
• Morphological and biochemical evaluations of tumor tissues.
• Metabolomic analysis using proton nuclear magnetic resonance (¹H NMR) spectroscopy.
• Verification of molecular pathways through immunoblotting and quantitative reverse transcription polymerase chain reaction (qRT-PCR).

Main Results:

• GLA treatment significantly altered tissue morphology, as evidenced by carmine and H&E staining, and scanning electron microscopy.
• ¹H NMR studies identified fifteen key serum metabolites related to amino acid and fatty acid metabolism affected by GLA.
• Immunoblotting and qRT-PCR confirmed that GLA mediates mitochondrial apoptosis, reduces the hypoxic microenvironment, inhibits de novo fatty acid synthesis, and activates the cholinergic anti-inflammatory pathway.

Conclusions:

• Gamma linolenic acid (GLA) exhibits significant anticancer properties against DMBA-induced mammary gland carcinoma.
• GLA exerts its effects through multiple mechanisms, including the induction of apoptosis, modulation of the tumor microenvironment, and regulation of metabolic pathways.
• GLA holds promise as a potential therapeutic agent for mammary gland carcinoma, warranting further investigation.